Literature DB >> 14689407

The value of preoperative pharmacologic stress testing before vascular surgery using ACC/AHA guidelines: a prospective, randomized trial.

Rita A Falcone1, Caitlin Nass, Roland Jermyn, Christine M Hale, Tracey Stierer, Calvin E Jones, Gerald K Walters, Lee A Fleisher.   

Abstract

OBJECTIVE: To evaluate the validity of preoperative cardiac stress testing using clinical predictors from the American College of Cardiology/American Heart Association Guidelines on Perioperative Evaluation before Noncardiac Surgery in patients undergoing vascular surgery.
DESIGN: Prospective, randomized pilot study.
SETTING: Academic medical center. PARTICIPANTS: Patients undergoing elective abdominal aortic, infrainguinal, and carotid vascular surgery.
INTERVENTIONS: After stratification by American College of Cardiology/American Heart Association (ACC/AHA) Guideline parameters, 99 patients were randomized to preoperative cardiac stress testing or to no stress testing and followed for up to 12 months postoperatively for adverse cardiac outcomes.
MEASUREMENTS AND MAIN RESULTS: Before hospital discharge of 46 patients who underwent preoperative stress testing, 7 (15%) had inducible ischemia with no adverse postoperative cardiac outcomes, whereas only 1 (3%) of 39 patients (85%) with no ischemia had a nonfatal adverse cardiac outcome (p = not significant). Of 53 patients without preoperative stress testing, only 2 (4%) had a nonfatal adverse postoperative cardiac outcome. There were no cardiac deaths. At 12-month follow-up in 79 (80%) patients, there was 1 nonfatal adverse cardiac outcome (no stress test) and 1 cardiac death (abnormal stress test), reflecting a 1% 12-month cardiac morbidity and mortality.
CONCLUSION: In this small prospective, randomized study evaluating the validity of preoperative cardiac stress testing using ACC/AHA Guidelines before major vascular surgery, preoperative cardiac stress testing offered no incremental value for determining postoperative adverse cardiac outcomes. Larger randomized clinical trials are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14689407     DOI: 10.1053/j.jvca.2003.09.004

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

1.  Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.

Authors:  Ji Hyun Yang; Jin Ho Choi; Young-Wook Ki; Dong Ik Kim; Duk-Kyung Kim; Jeong Rang Park; Jae K Oh; Seung-Hyuk Choi
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

2.  Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery.

Authors:  J-H Choi; D K Cho; Y-B Song; J-Y Hahn; S Choi; H-C Gwon; D-K Kim; S H Lee; J K Oh; E-S Jeon
Journal:  Heart       Date:  2009-10-26       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.